Treatment of tick and flea infestations.

  • This veterinary medicinal product is a systemic insecticide and acaricide which ensures:

– immediate and persistent insecticidal activity on fleas (Ctenocephalides felis) for 12 weeks;

– immediate and persistent acaricidal activity on ticks for 12 weeks for Ixodes ricinus, Dermacentor reticulatus and Dermacentor variabilis;

– immediate and persistent acaricidal activity on ticks for 8 weeks for Rhipicephalus sanguineus.

In order to be exposed to the active substance, fleas and ticks must be present on the animal and have started feeding. The effect on fleas begins within 8 hours (C. felis) and within 12 hours for ticks (I. ricinus).

The product can be used as part of a flea bite allergic dermatitis (flea bite allergic dermatitis) treatment plan.

Treatment of demodicosis caused by Demodex canis.

Treatment of infestations by sarcoptic mange (Sarcoptes scabiei var. canis).

Oral route.

  • Method of administration:

Administer Bravecto chewable tablets at or around meal time.

Bravecto is a chewable tablet and is well accepted by most dogs. If the tablet is not taken voluntarily by the dog, it can also be given with food or directly into the mouth. The dog should be monitored during administration to ensure that the tablet has been ingested.

  • Treatment program:

For optimal control of flea infestation, the veterinary medicinal product should be administered at 12-week intervals. For optimal control of tick infestation, the reprocessing schedule depends on the tick species. See section 4.2.

For the treatment of Demodex canis infestations, a single dose of the product should be administered. As demodicosis is a multifactorial disease, it is recommended that any underlying disease be treated appropriately as well.

For the treatment of infestations with sarcoptic mange (Sarcoptes scabiei var. canis), a single dose of the product should be administered. The necessity and frequency of re-treatment must be in accordance with the advice of the prescribing veterinarian.

Categories: ,